Skip to main content

Published locations for Large cohort study: Bevacizumab safe, effective for severe HHT bleeds

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Large cohort study: Bevacizumab safe, effective for severe HHT bleeds

User login

  • Reset your password
  • /content/large-cohort-study-bevacizumab-safe-effective-severe-hht-bleeds
  • /familypracticenews/article/226226/bleeding-disorders/large-cohort-study-bevacizumab-safe-effective
  • /hematologynews/article/226226/bleeding-disorders/large-cohort-study-bevacizumab-safe-effective
  • /internalmedicinenews/article/226226/bleeding-disorders/large-cohort-study-bevacizumab-safe-effective
  • /hematology-oncology/article/226226/bleeding-disorders/large-cohort-study-bevacizumab-safe-effective
  • /internalmedicine/article/226226/bleeding-disorders/large-cohort-study-bevacizumab-safe-effective
  • /familymedicine/article/226226/bleeding-disorders/large-cohort-study-bevacizumab-safe-effective